Skip to main content
OpenTrials

Clinical trial condition

AIDS-Related Complex

Explore clinical trials studying AIDS-Related Complex. Study availability and eligibility vary by location and protocol.

272 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

AIDS-Related Complex trial results

Completed

A Phase I Study of Methotrexate for HIV Infection

NCT00000834

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +18 more
Locations
  • Cedars Sinai Med Ctr Los Angeles, California, United States
  • Georgetown Univ Med Ctr Washington D.C., District of Columbia, United States
  • Univ of Kansas School of Medicine Wichita, Kansas, United States
  • New England Med Ctr Boston, Massachusetts, United States
View Trial Details
Completed

A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy of Prednisone Therapy in HIV-Associated Nephropathy (HIVAN)

NCT00000819

Conditions
AIDS-Associated Nephropathy, AIDS-Related Complex, Blood-Borne Infections, +19 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • Harbor-UCLA Med. Ctr. CRS Torrance, California, United States
  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States
View Trial Details
Completed

Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children

NCT00000773

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, +24 more
Locations
  • UCSF Pediatric AIDS CRS San Francisco, California, United States
  • Chicago Children's CRS Chicago, Illinois, United States
  • Tulane/LSU Maternal/Child CRS New Orleans, Louisiana, United States
  • DUMC Ped. CRS Durham, North Carolina, United States
View Trial Details
Completed

A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection

NCT00000812

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • University of Minnesota, ACTU Minneapolis, Minnesota, United States
  • Memorial Sloan-Kettering Cancer Ctr. New York, United States
  • Unc Aids Crs Chapel Hill, North Carolina, United States
View Trial Details
Completed

A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons

NCT00000743

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU New Orleans, Louisiana, United States
  • Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States
  • Unc Aids Crs Chapel Hill, North Carolina, United States
View Trial Details
Completed

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group

NCT00000815

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +18 more
Locations
  • UAB, Dept. of Ped., Div. of Infectious Diseases Birmingham, Alabama, United States
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States
View all 46 locations
View Trial Details
Completed

A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection

NCT00000750

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Univ of Alabama at Birmingham Schl of Med / Pediatrics Birmingham, Alabama, United States
  • Kaiser Permanente / UCLA Med Ctr Downey, California, United States
  • UCLA Med Ctr / Pediatric Los Angeles, California, United States
  • Harbor - UCLA Med Ctr / UCLA School of Medicine Los Angeles, California, United States
View all 42 locations
View Trial Details
Completed

A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy

NCT00000820

Conditions
AIDS-Related Complex, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States
  • SUNY - Buffalo, Erie County Medical Ctr. Buffalo, New York, United States
View Trial Details

Related conditions